Skip to main content
. 2023 Jun 1;228(8):1033–1041. doi: 10.1093/infdis/jiad195

Figure 3.

Figure 3.

Incidence of hospitalization or death within 30 days and absolute risk difference among patients who received molnupiravir and controls. Results for the matched groups. Abbreviations: BMI, body mass index; CI, confidence interval; COPD, chronic obstructive pulmonary disease; MPV, molnupiravir.